Comparison of Extremely Obese Patients Undergoing Gastric Sleeve Surgery

Sponsor
University of Pecs (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05929170
Collaborator
(none)
160
1
27
5.9

Study Details

Study Description

Brief Summary

By the comparison of the preoperative and postoperative data of approximately 160 patients undergoing gastric sleeve surgery, we try to draw conclusions about the effectiveness of gastric sleeve surgery, expected complication rate.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    We plan to compare the preoperative and postoperative data of approximately 160 patients undergoing gastric sleeve surgery (android-gynoid, male-female, comparison of patients with different degree of obesity, age comparison, etc.) Many preoperative and postoperative data are known about the patients (weight, height, BMI, preoperative comorbidities, heart ultrasound values, respiratory function values, laboratory parameters, smoking habits, rate of weight loss in half a year and one year, etc.). By statistical analysis of these data, we try to draw conclusions about the effectiveness of gastric sleeve surgery, expected complication rate, etc.,

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    160 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Comparison of Different Tipe Extremely Obese Patients Undergoing Gastric Sleeve Surgery in Terms of Perioperative Risk (Cardiopulmonary Parameters and Other Perioperative Risk Factors) and Effectiveness of the Intervention
    Actual Study Start Date :
    Apr 1, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2023
    Anticipated Study Completion Date :
    Jul 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Assessing the results of gastric sleeve surgery, by weight loss [up to one year]

      weight loss (kg)

    Secondary Outcome Measures

    1. Assessing the half and one-year results of gastric sleeve surgery, by change in comorbidities [half year, one year]

      change in comorbidities (the clinical improvement of the given comorbidity, for example in the case of hypertension, the patient's antihypertensive medications can be reduced or completely omitted, ect.)

    2. Assessing the half and one-year results of gastric sleeve surgery, comparing different groups (male-female, android-gynoid tipe of obesity, ect.) [half year, one year]

      weight loss (kg)

    3. Assessing the half and one-year results of gastric sleeve surgery, weight loss. (We try to find a confluence between the perioperative parameters and the expected outcome) [half year, one year]

      weight loss (kg)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Obesity (BMI higher than 30 kg/m2)

    Exclusion Criteria:

    Lack of patient consent to the study, Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Siptár Miklós Pécs Hungary 7635

    Sponsors and Collaborators

    • University of Pecs

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Siptár Miklós, Anesthesiologist and ICU specialist, University of Pecs
    ClinicalTrials.gov Identifier:
    NCT05929170
    Other Study ID Numbers:
    • 8653-PTE 2021.
    First Posted:
    Jul 3, 2023
    Last Update Posted:
    Jul 3, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Siptár Miklós, Anesthesiologist and ICU specialist, University of Pecs
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 3, 2023